Document Detail


Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
MedLine Citation:
PMID:  17593624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Selection of the human drug sensitive and invasive cell line (MDA-MB-435S-F) with the chemotherapeutic agent paclitaxel, resulted in the development of drug resistant cell lines displaying enhanced invasion-related characteristics. MATERIALS AND METHODS: Serum-free conditioned media from the human cancer drug-sensitive and invasive cell line (MDA-MB-435S-F) and its paclitaxel-resistant superinvasive variant (MDA-MB-435S-F/Taxol10p4pSI) were analyzed using Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). RESULTS: A differentially expressed protein was observed at 7.6 kDa, which was 4-fold up-regulated in MDA-MB-435S-F/Taxol10p4pSI. The differentially expressed protein was identified using matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry (MALDI-TOF/TOF MS), as a fragment of bovine transferrin. The transferrin receptor was also found to be overexpressed in the superinvasive cell line. CONCLUSION: Cleavage of serum proteins such as transferrin could provide a valuable source of markers for malignant tumours and could also play a role in aspects of cancer pathogenesis, such as tumour cachexia.
Authors:
P Dowling; P Maurya; P Meleady; S A Glynn; A J Dowd; M Henry; M Clynes
Related Documents :
2227544 - Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplat...
9689134 - Desoxyepothilone b: an efficacious microtubule-targeted antitumor agent with a promisin...
22544364 - A genome-wide association study identifies susceptibility loci for wilms tumor.
22466864 - Frequent aberrant expression of the human ether à go-go (heag1) potassium channel in h...
1268854 - Growth support of small b16 melanoma implants with nitrosourea-sterilized fractions of ...
10880764 - Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  27     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    2007 May-Jun
Date Detail:
Created Date:  2007-06-27     Completed Date:  2007-07-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1309-17     Citation Subset:  IM    
Affiliation:
National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. paul.dowling@dcu.ie
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Breast Neoplasms / chemistry*,  drug therapy,  metabolism,  pathology
Cell Line, Tumor
Culture Media, Conditioned
Drug Resistance, Neoplasm
Female
Humans
Neoplasm Invasiveness
Neoplasm Proteins / chemistry,  isolation & purification*
Paclitaxel / pharmacology
Peptide Fragments / chemistry,  isolation & purification*
Receptors, Transferrin / biosynthesis,  chemistry,  isolation & purification
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods
Transferrin / chemistry,  isolation & purification*
Tumor Markers, Biological / chemistry,  isolation & purification*
Chemical
Reg. No./Substance:
0/Culture Media, Conditioned; 0/Neoplasm Proteins; 0/Peptide Fragments; 0/Receptors, Transferrin; 0/Tumor Markers, Biological; 11096-37-0/Transferrin; 33069-62-4/Paclitaxel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Real-time quantitative reverse transcriptase-polymerase chain reaction analysis of melanoma progress...
Next Document:  Global mRNA analysis to determine a transcriptome profile of cancer stemness in a mouse model.